To assess the sensitivity of pain DMRs to methylation quantification of MeDIP-seq data, we also performed analyses controlling for CpG density 29 and MeDIP-seq fragment size in the discovery sample ( Supplementary Figs S7 and S8 ), and found that the majority of top-ranked pain DMRs remained nominally significant, although their relative rank could change.
1
—
—